Gregory K Hartig, MD, FACS

Professor

  • Chief, Section of Head and Neck Surgical Oncology
  • Division of Otolaryngology-Head & Neck Surgery

hartig@surgery.wisc.edu
(608) 265-8207

600 Highland Ave
MC 7375
Madison, WI 53792-3284

Education

  • MD, University of Michigan, Ann Arbor, MI, 1988
  • Internship, St. Joseph Mercy Hospital, Ann Arbor, MI, 1988-1989
  • Residency, University of Michigan, Ann Arbor, MI, 1989-1993
  • Fellow, Head and Neck Reconstructive Surgery, University of Pennsylvania Medical Center, Philadelphia, PA, 1993-1994

Clinical Specialties

Dr. Hartig is certified by the American Board of Otolaryngology-Head and Neck Surgery. His practice combines traditional head and neck surgery with facial plastic and reconstructive surgery. He has extensive experience managing head and neck cancer, including tumors of the skull base, and performing microvascular free tissue transfer reconstruction. Dr. Hartig directs the head and neck oncology program at UW Hospital and Clinics.

Research Interests

Dr. Hartig has research interests in the cytogenetics of head and neck carcinoma, free flap physiology, and airway reconstruction.

Recent Publications

  • Clinical outcomes for larynx patients with cancer treated with refinement of high-dose radiation treatment volumes.
    Burr AR, Harari PM, Haasl AM, Wieland AM, Bruce JY, Kimple RJ, Hartig GK, McCulloch TM, Witek ME
    Head Neck 2020 Feb 14;
    [PubMed ID: 32057151]

  • Clinical Implications of Scleroderma in the Decision for Radiotherapy-Based Larynx Preservation.
    Rydzewski NR, Harari PM, Hartig GK, Francis D, Witek ME
    JAMA Otolaryngol Head Neck Surg 2019 Dec 12;
    [PubMed ID: 31830220]

  • Auriculotemporal Nerve Involvement in Parotid Bed Malignancy.
    Thompson JD, Avey GD, Wieland AM, Harari PM, Glazer TA, McCulloch TM, Hartig GK
    Ann. Otol. Rhinol. Laryngol. 2019 Jul; 128(7): 647-653
    [PubMed ID: 30894024]

  • Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review.
    Bowen RC, Ko HC, Avey GD, Hartig GK, Hu R, Harari PM, Lucarelli MJ
    Pract Radiat Oncol 2019 May; 9(3): 136-141
    [PubMed ID: 30731273]

  • A Comparison of E6H4 and G175-405 p16-specific Monoclonal Antibodies in Oropharyngeal Squamous Cell Carcinoma.
    Ennis CM, Rohrbach MR, Schwalbe M, Mahajan A, Hartig GK
    Appl. Immunohistochem. Mol. Morphol. 2020 Apr; 28(4): 290-295
    [PubMed ID: 30664533]

All Publications on PubMed